Skip to main content

Bivalent Oral Poliomyelitis Vaccine Type 1&3 (bOPV 1&3)

Product overview

Type
Polio Vaccine - Oral (OPV) Bivalent Types 1 and 3
Commercial Name
Bivalent Oral Poliomyelitis Vaccine Type 1&3 (bOPV 1&3)
Manufacturer
PT Bio Farma (Persero)
Responsible NRA
National Agency of Drug and Food Control Indonesia
Country
Indonesia

Prequalification

Prequalification Status
Current
Effective Date

Product description

Pharmaceutical Form
Liquid: ready to use
Presentation
Vial
Number of Doses
10
Diluent
Not Applicable
Route of Administration
Oral
Shelf Life
24 months
Storage Temperature
-20°C
Vaccine Vial Monitor
Type 2
Secondary Packaging
carton of 10 vials (8.5 x 3.85 x 4.25 cm)
Tertiary Packaging
Insulated shipping box of 65 x 51 x 60 cm, containing 2700 vials (with icepack) or 3200 vials (with dry ice)
Multidose Vial Policy
WHO recommends that opened vials of this vaccine may be kept for use in subsequent immunization sessions (up to a maximum of 28 days) provided the conditions outlined in the WHO Policy Statement: The use of opened multi-dose vials of vaccine in subsequent immunization sessions are met.
Vaccine Preservative
none
Cold Chain Volume
1.4 cm3/dose (in secondary packaging)

Attachments

VPSAR (Vaccine Public Summary Assessment Report)
Package Insert
Container Photo
Container Photo